ArticleFrontiers in oncology2023

Immunogenic cell death-associated biomarkers classification predicts prognosis and immunotherapy efficacy in pancreatic ductal adenocarcinoma.

Wenguang Peng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.